Regeneron Claims Its Covid-19 Antibody Therapy Demonstrated Promise in Hospitalised Patients

Casirivimab and imdevimab are not authorised for use in patients who are hospitalised or require oxygen therapy due to Covid-19, or for people currently using chronic oxygen therapy because of an...

from NDTV Profit - Latest https://ift.tt/3ptPJMC
via